Human C-reactive protein: expression, structure, and function
- PMID: 11532280
- DOI: 10.1016/s0161-5890(01)00042-6
Human C-reactive protein: expression, structure, and function
Abstract
C-reactive protein (CRP) is an acute-phase protein featuring a homopentameric structure and Ca-binding specificity for phosphocholine (PCh). Expression of CRP is regulated mainly at the transcriptional level with interleukin-6 being the principal inducer of the gene during the acute phase. The crystal structure of CRP has been determined and the topology and chemical composition of its ligand-binding site determined. The wide distribution of PCh in polysaccharides of pathogens and in cellular membranes allows CRP to recognize a range of pathogenic targets as well as membranes of damaged and necrotic host cells. CRP bound to a multivalent ligand can efficiently initiate the assembly of a C3 convertase through the classical pathway and thus decorate the surface of the ligand with opsonic complement fragments. However, the protein does not favor the formation of a C5 convertase and therefore, CRP-initiated complement activation does not mediate acute inflammatory reactions and membrane damage. CRP also interacts with Fc receptors on phagocytic cells and acts as an opsonin. Other CRP-initiated signals through interactions with neutrophil Fc receptors have an overall anti-inflammatory effect. Thus, the main biological function of CRP appears to be host defense against bacterial pathogens and clearance of apoptotic and necrotic cells. Protection from lethal bacterial infection, from complement-induced alveolitis, and from endotoxemia has been confirmed in vivo using transgenic mice. Additional functions, including participation in atherogenesis and pathogenesis of myocardial injury after myocardial infarction have been reported. However, the weight of the evidence is that CRP like other acute-phase proteins is a component first line of innate host defense.
Similar articles
-
[Is C-reactive protein a marker of inflammation?].Nephrologie. 2003;24(7):337-41. Nephrologie. 2003. PMID: 14650743 Review. French.
-
The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.Mol Immunol. 2003 Jun;39(16):1045-54. doi: 10.1016/s0161-5890(03)00031-2. Mol Immunol. 2003. PMID: 12749911
-
Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.J Immunol. 2002 Jun 15;168(12):6375-81. doi: 10.4049/jimmunol.168.12.6375. J Immunol. 2002. PMID: 12055255
-
C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells.J Immunol. 2007 Jun 1;178(11):7283-91. doi: 10.4049/jimmunol.178.11.7283. J Immunol. 2007. PMID: 17513778
-
C-reactive protein reactivity with complement and effects on phagocytosis.Ann N Y Acad Sci. 1982;389:251-62. doi: 10.1111/j.1749-6632.1982.tb22141.x. Ann N Y Acad Sci. 1982. PMID: 7046579 Review.
Cited by
-
Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer.Cancers (Basel). 2020 Oct 9;12(10):2899. doi: 10.3390/cancers12102899. Cancers (Basel). 2020. PMID: 33050319 Free PMC article.
-
Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past.Int J Med Sci. 2021 Mar 3;18(8):1886-1898. doi: 10.7150/ijms.54787. eCollection 2021. Int J Med Sci. 2021. PMID: 33746606 Free PMC article. Review.
-
C-reactive protein isoforms as prognostic markers of COVID-19 severity.Front Immunol. 2023 Jan 18;13:1105343. doi: 10.3389/fimmu.2022.1105343. eCollection 2022. Front Immunol. 2023. PMID: 36741367 Free PMC article.
-
Generation and biological activities of oxidized phospholipids.Antioxid Redox Signal. 2010 Apr 15;12(8):1009-59. doi: 10.1089/ars.2009.2597. Antioxid Redox Signal. 2010. PMID: 19686040 Free PMC article. Review.
-
C-reactive protein is a predictor of severe infective complications following gastrectomy-a retrospective analysis.J Gastrointest Oncol. 2023 Feb 28;14(1):64-72. doi: 10.21037/jgo-22-675. Epub 2022 Dec 27. J Gastrointest Oncol. 2023. PMID: 36915451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous